research, asthma, diabetes, obesity, osteoporosis, arthritis

Merck Frosst is firmly rooted in Canadašs history of scientific research. In 2000, Merck Frosst invested over 100 million dollars in research and development. This amount represents 11% of R & D expenditures for the entire pharmaceutical industry in Canada. This investment allows Merck Frosst to discover new medications for respiratory conditions such as asthma, and inflammatory conditions such as arthritis.